These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 37175726)

  • 1. The Role of Microbiota-Derived Metabolites in Colorectal Cancer.
    Duizer C; de Zoete MR
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of microbial products in the development of colorectal cancer: a review.
    Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
    Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-derived metabolites in CRC progression and causation.
    Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota and beneficial metabolites in colorectal cancer.
    González A; Fullaondo A; Odriozola I; Odriozola A
    Adv Genet; 2024; 112():367-409. PubMed ID: 39396841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota and detrimental protein derived metabolites in colorectal cancer.
    González A; Odriozola I; Fullaondo A; Odriozola A
    Adv Genet; 2024; 112():255-308. PubMed ID: 39396838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota and other detrimental metabolites in colorectal cancer.
    González A; Fullaondo A; Odriozola I; Odriozola A
    Adv Genet; 2024; 112():309-365. PubMed ID: 39396839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications.
    Yin T; Zhang X; Xiong Y; Li B; Guo D; Sha Z; Lin X; Wu H
    Microbiol Res; 2024 Nov; 288():127871. PubMed ID: 39137590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
    Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial metabolites as modulators of host physiology.
    Joyce SA; Clarke DJ
    Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer.
    Hamamah S; Lobiuc A; Covasa M
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease.
    Masse KE; Lu VB
    Front Endocrinol (Lausanne); 2023; 14():1169624. PubMed ID: 37560311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
    Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
    Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
    Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the gut microbiome, metabolites, and multi-omics biomarkers across the colorectal cancer care continuum.
    Wu Y; Shen N; Hope C; Noh HI; Richardson BN; Swartz MC; Bai J
    Benef Microbes; 2024 Aug; 15(6):539-563. PubMed ID: 39147373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Metabolite Dysbiosis and Colorectal Cancer.
    Niekamp P; Kim CH
    Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of microbiota-derived metabolites on viral infections.
    Alwin A; Karst SM
    Curr Opin Virol; 2021 Aug; 49():151-156. PubMed ID: 34144380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Fecal Gut Microbiota, Short-Chain Fatty Acids and Bile Acids Link Colorectal Cancer Risk to Dietary Changes Associated with Urbanization Among Zimbabweans.
    Katsidzira L; Ocvirk S; Wilson A; Li J; Mahachi CB; Soni D; DeLany J; Nicholson JK; Zoetendal EG; O'Keefe SJD
    Nutr Cancer; 2019; 71(8):1313-1324. PubMed ID: 31007075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.